FDA Drug Application (205718) for AKYNZEO by HELSINN HLTHCARE

Back to FDA Applications sponsored by HELSINN HLTHCARE

Application Number205718
Product Number001
FormCAPSULE;ORAL
Dosage300MG;EQ 0.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAKYNZEO
Active IngredientNETUPITANT; PALONOSETRON HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient PALONOSETRON HYDROCHLORIDE4


Back to FDA Applications sponsored by HELSINN HLTHCARE